Colorectal and gastric cancer: Current and future therapeutic approaches. Part 3 - Future developments

December 06, 2023 00:17:57
Colorectal and gastric cancer: Current and future therapeutic approaches. Part 3 - Future developments
COR2ED - Oncology Medical Conversation
Colorectal and gastric cancer: Current and future therapeutic approaches. Part 3 - Future developments

Dec 06 2023 | 00:17:57

/

Show Notes

In this podcast series, Dr. Jenny Seligmann (University of Leeds, UK), Dr. Autumn McRee (University of North Carolina, USA) and Dr. Dominik Modest (Charité University of Medicine, Germany) discuss the different therapeutic options available in colorectal and gastric cancer.

In this third episode, the experts turn their focus to earlier stage disease and consider how lessons learnt in the treatment of metastatic disease can be applied in the neo adjuvant setting for colorectal cancer by discussing data from the FOXTROT and NICHE trials and the adjuvant setting for gastric cancer by discussing data from CheckMate 577. Finally, the experts consider new promising data on targeting KRAS compared to the MEK and the ERK inhibitors.

Other Episodes

Episode

December 07, 2023 00:22:35
Episode Cover

Precision oncology: An overview of tumour agnostic therapies

What are tumour agnostic cancer treatments and which biomarkers do they target? Join Prof. David Hong (Medical Oncologist at MD Anderson Cancer Center, Houston,...

Listen

Episode

April 25, 2024 00:27:48
Episode Cover

Câncer de pulmão: Desafios da fase pré-analítica e teste de biomarcadores

Quais são os desafios mais comuns na fase pré-analítica na luta contra o câncer de pulmão e como podemos superá-los? Qual a importância de...

Listen

Episode

December 06, 2023 00:31:03
Episode Cover

Prostate cancer: Genetic testing and PARP inhibitors in prostate cancer

COR2ED Medical Education: Joanne Chien, Nurse Practitioner specialising in urologic cancers at Stanford Health Care in Palo Alto, California, and Dr Alexander Wyatt, Assistant...

Listen